Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)
Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC). The update note ...
Zacks Small Cap Issues Negative Forecast for ENSC Earnings
Investment analysts at Zacks Small Cap reduced their Q1 2025 EPS estimates for shares of Ensysce Biosciences in a research report issued to clients and investors on Tuesday, March 11th. Zacks Small ...
Ensysce Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results
Secures Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPARGroundbreaking Trial on PF614-MPAR Generates Positive Interim Results SAN DIEGO, CA / ACCESS Newswire / M ...
Yahoo Finance5d
Ensysce Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results
SAN DIEGO, CA / ACCESS Newswire / March 10, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for ...